Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 36.62M P/E - EPS this Y -24.20% Ern Qtrly Grth -
Income -35.03M Forward P/E -0.70 EPS next Y 29.60% 50D Avg Chg -34.00%
Sales 12M PEG - EPS past 5Y - 200D Avg Chg -30.00%
Dividend N/A Price/Book 3.36 EPS next 5Y - 52W High Chg -55.00%
Recommedations 2.00 Quick Ratio 0.94 Shares Outstanding 2.83M 52W Low Chg 31.00%
Insider Own 0.14% ROA -53.69% Shares Float 410.33M Beta 1.40
Inst Own 13.21% ROE - Shares Shorted/Prior 38.32K/37.17K Price 2.24
Gross Margin 100.00% Profit Margin -291.89% Avg. Volume 153,030 Target Price 72.00
Oper. Margin -291.03% Earnings Date Aug 9 Volume 56,753 Change -5.49%
About ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises eblasakimab (ASLAN004), a monoclonal antibody that targets the IL-13 receptor a1 subunit which is under Phase 2 developed for the treatment of atopic dermatitis and other immunology indications; and farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase currently under Phase 2 clinical trials for the treatment of autoimmune diseases. It has research collaboration agreement with Zenyaku Kogyo Co., Ltd. for the development and commercialization of eblasakimab in atopic dermatitis and all other indications in Japan. The company was founded in 2010 and is headquartered in Singapore.

ASLAN Pharmaceuticals Limited News
07/17/24 Top Midday Decliners
07/17/24 ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
07/15/24 Sector Update: Health Care Stocks Edge Lower Late Afternoon
07/15/24 ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
06/14/24 ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
06/04/24 All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy
06/04/24 Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher
06:00 AM ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
05/09/24 ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
05/07/24 ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
05/02/24 ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
04/30/24 ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
04/24/24 ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
04/22/24 ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
04/19/24 ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
04/12/24 ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
04/09/24 Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
03/27/24 Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
03/20/24 Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
03/12/24 ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
ASLN Chatroom

User Image goodetrades Posted - 2 days ago

$ASLN If anyone is tired of waiting for something to happen, I would be happy to buy your shares from you at $0.60 (the close on the last trading day). DM me for details. I'm short and while I'm not paying very expensive borrow I would like to clear this off my books and move on.

User Image 10BillyBiggs Posted - 1 week ago

$ASLN What a call 🫡 Well take your word for $ALT

User Image SQUEAKSBANDIT Posted - 2 weeks ago

how many shares do you guys have i have 1k @ .60 $ASLN

User Image Target25 Posted - 10/25/24

$ASLN is this gonna be tradeable in Robinhood again ?

User Image jkitna Posted - 1 month ago

@Janedo @SQUEAKSBANDIT To summarize my understanding of a frustrating conversation w/ broker, we need to elect to tender ADR shares or let the tender offer expire. If the offer expires, the agent will close the ADR position & attempt to sell the shares & remit whatever cash they obtain to the holder. If you tender the ADRs, you'll receive 250 shares for each ADR but can't sell them without going directly to the broker. On your behalf, the broker can attempt to sell the shares on a "best-efforts" basis by locating a foreign broker to execute the trade, but there are no guarantees they'll be able to sell the shares. Per the offer terms, if you tender your ADR shares, there is a cable fee of $15, a cancelations fee of $.05 per ADR (rounding off to nearest 100 shares surrendered) and a voluntary $25 corporate action fee. While I liked the opportunity here, I think managing this position & the tax reporting will be more trouble than it's worth and comes with yet another charge. $ASLN

User Image SQUEAKSBANDIT Posted - 1 month ago

$ASLN would it benefit us in any way to convert to ordinary shares? could they even be held in a standard us brokerage account? do the ordinaries currently trade in Singapore?

User Image redfox43202 Posted - 1 month ago

$ASLN I got notification from Fidelity that JPM is about to liquidate ADR, we have options to convert to 200 shares to avoid that. So I contacted the liquidator about the status of the liquidation. Here is what she replied: Please be informed that we are only appointed as the liquidator for Aslan Pharmaceuticals Pte Ltd (In Creditors’ Voluntary Liquidation) (“Aslan SG”) and Quantuma is not appointed to Aslan Pharmaceuticals Limited (“Aslan KY”). However, we understand that a creditor of Aslan Pharmaceuticals Limited is in the midst of preparing a Petition to file in the Grand Court of the Cayman Islands seeking to place it into Official Liquidation. Once Aslan KY is placed into liquidation, the relevant parties will reach out to you for the next steps. Thank you. Pei Shi Foo Senior Associate Quantuma International UK | ASIA-PACIFIC | CARIBBEAN | MIDDLE EAST

User Image redfox43202 Posted - 3 months ago

$ASLN How many times have we been charged fees in the past 6 months? My recent one was July 15. Last two charges brought my IRA to negative cash balance. Are there anymore coming?

User Image erich006 Posted - 3 months ago

$ASLN anyone got insights into next steps?

User Image Stormra Posted - 07/31/24

$ASLN this is a wild question but could they be selling the company?

User Image Stormra Posted - 07/30/24

$ASLN Part 2

User Image Stormra Posted - 07/30/24

$ASLN I emailed them to see what was going on. Part 1

User Image Ricky82 Posted - 07/29/24

$ASLN people here post bullish are paid pumpers. Stocktwit is full of paid aholes like people on $JAGX . Shame on you

User Image Stormra Posted - 07/24/24

$ASLN What happens next?

User Image lousjamsession Posted - 07/23/24

$ASLN

User Image Peteryoussef287 Posted - 07/22/24

$ASLN

User Image paradox83 Posted - 07/22/24

$ASLN will it trade on OTC ?

User Image Stocksrockman Posted - 4 months ago

$ASLN $MYSZ $NTRP $PBM MYSZ is ready

User Image bandido20 Posted - 4 months ago

$MYSZ 550k float getting a lot of attention, finished the week with 3 times the average volume and less than 4K shares left to borrow at a cost of 77%. Imo primed for continuation on monday and upside move. Volume precedes price action. $ASLN 👀 bio stock $pbm will move again $NTRP had nice news

User Image erich006 Posted - 4 months ago

$ASLN https://listingcenter.nasdaq.com/IssuersPendingSuspensionDelisting.aspx Looks like today 7/19 officially suspended from Nasdaq… ugh

User Image SQUEAKSBANDIT Posted - 4 months ago

$ASLN this ting quoted on the bb symbol?

User Image Trancehead75 Posted - 4 months ago

$ASLN People! They’re liquidating their entire asset portfolio! Don’t listen to the pumpers trying to make some minimal gains outta their heavy losses! Don’t fall into the trap!

User Image TheLearnerEarner Posted - 4 months ago

$ASLN added HUGELY UNDERVALUED stock swing trade - healthcare - micro cap - 2/9 F-Score - extraordinary intrinsic value potential - 10x relative volume - Piper Sandler overweight rating - H.C. Wainwright buy rating - short term gains 💱 Unusual Volume Activity 🚀 RSI: 21.74 (oversold) 📊 Analyst Price Target: $9.50 (1457.38% above Price) 🌟 Range (12m) $0.48 - $22.96 💰 *** BE PREPARED FOR POTENTIAL BANKRUPTCY OR DELISTING SOON *** NEWSDESK (article idea is for ASLN only) 📰 https://finance.yahoo.com/news/aslan-pharmaceuticals-announces-filed-voluntary-112500259.html

User Image CABTC Posted - 4 months ago

$ASLN $CTXR $MWG Eyes also on $AMIX, nice

User Image CABTC Posted - 4 months ago

$MWG - Hidden gem, I’ve loaded the boat $CTXR - Beauty of a stock $ASLN - Also lovely

User Image PLATINUM_TRADES Posted - 4 months ago

$ASLN trying $.60 for fun.... Let's see 🐐 🐐

User Image PLATINUM_TRADES Posted - 4 months ago

$ASLN these delisting bounces happen so often.. I've seen them double.. Tiny floater, oversold... Could make a run for a $1.00 in my opinion just to screw with Nasdaq.... Bounce could be a good one from here.. $.81 next resistance 🥊🥊🥊🥊

User Image Stormra Posted - 4 months ago

$ASLN Benzinga1 hour ago "The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. ` An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here's the latest list of major oversold players in this sector, having an RSI near or below 30. Aslan Pharmaceuticals Ltd (NASDAQ:ASLN) On July 17, ASLAN Pharmaceuticals (ASLN.NaE) announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation. The company said this decision was made following a thorough review of ASLAN SG's financial situation and strategic options. The company's stock fell around 69% over the past five days and has a 52-week low of $0.48. RSI Value: 25.34 ASLN Price Action: Shares of Aslan Pharmaceuticals (ASLN.NaE) fell 37% to close at $0.70 on Wednesday. Benzinga Pro's real-time newsfeed alerted to latest Aslan Pharmaceuticals (ASLN.NaE) news."

User Image PLATINUM_TRADES Posted - 4 months ago

$ASLN bounce time? 🤔

User Image BOGGLE69 Posted - 4 months ago

$ASLN

Analyst Ratings
HC Wainwright & Co. Buy May 3, 24
HC Wainwright & Co. Buy Apr 23, 24
HC Wainwright & Co. Buy Apr 15, 24
HC Wainwright & Co. Buy Mar 18, 24
Piper Sandler Overweight Mar 13, 24
Piper Sandler Overweight Mar 11, 24
HC Wainwright & Co. Buy Nov 6, 23
Roth MKM Buy Aug 14, 23
HC Wainwright & Co. Buy Aug 14, 23